Routes of exposure: Topical and transdermal

REFERENCES

• Steinberg M., Borzelleca J.F., Enters E.K., Kinoshita F.K., Loper A., Mitchell D.B., Tamulinas C.B., Weiner M.L. The Safety Committee of the International Pharmaceutical Excipients Council. A New Approach to the Safety Assessment of Pharmaceutical Excipients. Regul. Toxicol. Pharmacol. 1996; 24: 149–154, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Detection of Toxicity to Reproduction for Medicinal Products. 1993.
   Google Scholar
• ICH. Toxicity to Male Fertility; an Addendum to the ICH Tripartite Guideline on Detection of Toxicity to Reproduction for Medicinal Products. 1995.
   Google Scholar
• ICH. Non-clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals. 1997.
   Google Scholar
• ICH. Guideline on the Need for Carcinogenicity Studies of Pharmaceuticals. 1995.
   Google Scholar
• ICH. Dose Selection for Carcinogenicity Studies of Pharmaceuticals. 1994.
   Google Scholar
• ICH. Testing for Carcinogenicity of Pharmaceuticals. 1997.
   Google Scholar
• Standard Test Method for Determining Subchronic Dermal Toxicity. ASTM, West Conshohocken 1996
   Google Scholar
• International Organization for Standardization (ISO). 10993-5 Test for Cytotoxicity: In Vitro Methods. Geneva, Switzerland, 1992.
   Google Scholar
• Organization for Economic Cooperation and Development (OECD). Guideline 406: Skin Sensitization, 1992.
   Google Scholar
• Code of Federal Regulations (CFR). Washington DC: US Government Printing Office, Title 16, 1500.41, 1997.
   Google Scholar
• CFR. Washington DC: US Government Printing Office, Title 21, 314.50 (d) (2) (ii), 1997.
   Google Scholar
• CFR. Washington DC: US Government Printing Office, Title 21, 58, 1997.
   Google Scholar
• Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration. Points to Consider in the Nonclinical Pharmacology/Toxicology Development of Topical Drugs Intended to Prevent the Transmission of Sexually Transmitted Diseases (STD) and/or for the Development of Drugs Intended to Act as Vaginal Contraceptives. Informal Communication under 21 CFR 10.90 (b) (9), 1996.
   Google Scholar
• Liu J.C., Wisniewski S.J. Recent Advances in Topical Drug Delivery Systems. Transdermal and Topical Drug Delivery Systems, T.K. Ghosh, W.R. Pfister, S.I. Yum. Interpharm Press, Buffalo Grove 1997; 593–612
   Google Scholar
• Pfister W.R. Transdermal and Dermal Therapeutic Systems: Current Status. Transdermal and Topical Drug Delivery Systems, T.K. Ghosh, W.R. Pfister, S.I. Yum. Interpharm Press, Buffalo Grove 1997; 33–112
   Google Scholar
• Berner B., Mazzenga G.C., Otte J.H., Steffens R.J., Juang R.H., Ebert C.D. Ethanol: Water Mutually Enhanced Transdermal Therapeutic System II: Skin Permeation of Ethanol and Nitroglycerin. J. Pharm. Sci. 1989; 78: 402–407, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Harrison J.E., Watkinson A.C., Green D.M., Hadgraft J., Brain K. The Relative Effect of Azone and Transcutol on Permeant Diffusivity and Solubility in Human Stratum Corneum. Pharm. Res. 1996; 13: 542–546, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Knutson K., Krill S.L., Zhang J. Solvent-Mediated Alterations of the Stratum Corneum. J. Controlled Release 1990; 11: 93–103, [CROSSREF]
   Web of Science ®Google Scholar
• Kasting G.B., Francis W.R., Roberts G.E. Skin Penetration Enhancement of Triprolidine Base by Propylene Glycol. J. Pharm. Sci. 1993; 82: 551–552, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lambert W.J., Higuchi W.I., Knutson K., Krill S.L. Dose-Dependent Enhancement Effects of Azone on Skin Permeability. Pharm. Res. 1989; 6: 798–803, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pershing L.K., Lambert L.D., Knutson K. Mechanism of Ethanol-Enhanced Estradiol Permeation Across Human Skin In Vivo. Pharm. Res. 1990; 7: 170–175, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tanojo H., Bouwstra J.A., Junginger H.E., Bodde H.E. In Vitro Human Skin Barrier Modulation by Fatty Acids: Skin Permeation and Thermal Analysis Studies. Pharm. Res. 1997; 14: 42–49, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yazdanian M., Chen E. The Effect of Diethylene Glycol Monoethyl Ether as a Vehicle for Topical Delivery of Ivermectin. Vet. Res. Commun. 1995; 19: 309–319, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Osborne D.W., Henke J.J. Skin Penetration Enhancers Cited in the Technical Literature. Pharm. Technol. 1997; 58–66, Nov.
   Google Scholar
• Chattaraj S.C., Walker R.B. Penetration Enhancer Classification. Percutaneous Penetration Enhancers, E.W. Smith, H.I. Maibach. CRC Press, Boca Raton, FL 1995; 5–20
   Google Scholar
• Roberts M.S., Singh J., Yoshida N., Currie K.I. Iontophoretic Transport of Selected Solutes Through Human Epidermis. Prediction of Percutaneous Penetration Methods, Measurements and Modeling, R.C. Scott, R.H. Guy, J. Hadgraft. IBC Technical Services, London 1989; 231–241, Proceedings of the conference held in April 1989
   Google Scholar
• Sage B.H., Riviere J.E. Model Systems in Iontophoresis—Transport Efficacy. Adv. Drug Deliv. Rev. 1992; 9: 265–287, [CROSSREF]
   Web of Science ®Google Scholar
• Singh P., Maibach H.I. Transdermal Iontophoresis Pharmacokinetic Considerations. Clin. Pharmacokinet. 1994; 26: 327–334, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Turner N.G., Ferry L., Price M., Cullander C., Guy R.H. Iontophoresis of Poly-l-Lysines: The Role of Molecular Weight?. Pharm. Res. 1997; 14: 1322–1331, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Meyer B.R., Kreis W., Eschbach J., O'Mara V., Rosen S., Sibalis D. Successful Transdermal Administration of Therapeutic Doses of a Polypeptide to Normal Human Volunteers. Clin. Pharmacol. Ther. 1988; 44: 607–612, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Meyer B.R., Kreis W., Eschbach J., O'Mara V., Rosen S., Sibalis D. Transdermal Versus Subcutaneous Leuprolide: A Comparison of Acute Pharmacodynamic Effect. Clin. Pharmacol. Ther. 1990; 48: 340–345, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ruddy S.B., Hadzija B.W. Iontophoretic Permeability of Polyethylene Glycols Through Hairless Rat Skin: Application of Hydrodynamic Theory for Hindered Transport through Liquid-Filled Pores. Drug Design Discov. 1992; 8: 207–224
   PubMedGoogle Scholar
• Green P.G., Hinz R.S., Kim A., Szoka F.C., Guy R.H. Iontophoretic Delivery of a Series of Tripeptides Across the Skin In Vitro. Pharm. Res. 1991; 8: 1121–1127, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pikal M.J., Shah S. Transport Mechanisms in Iontophoresis. III: An Experimental Study of the Contributions of Electroosmotic Flow and Permeability Change in the Transport of Low and High Molecular Weight Solutes. Pharm. Res. 1990; 7: 222–229, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hirvonen J., Guy R.H. Iontophoretic Delivery Across the Skin; Electroosmosis and Its Modulation by Drug Substances. Pharm. Res. 1997; 14: 1258–1263, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ruddy S.B., Hadzija B.W. The Role of Stratum Corneum in Electrically Facilitated Transdermal Drug Delivery. I: Influence of Hydration, Tape-Stripping and Delipidization on the DC Electrical Properties of Skin. J. Controlled Release 1995; 37: 225–238, [CROSSREF]
   Web of Science ®Google Scholar
• Elias P.M., Menon G.K. Structural and Lipid Biochemical Correlates of the Epidermal Permeability Barrier. Adv. Lipid Res. 1991; 24: 1–26, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Mitragotri S., Blankschtein D., Langer R. Transdermal Drug Delivery Using Low-Frequency Sonophoresis. Pharm. Res. 1996; 13: 411–420, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mitragotri S., Blankschtein D., Langer R. Ultrasound-Mediated Transdermal Protein Delivery. Science 1995; 269: 850–853, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Vanbever R., Le Boulenge E., Preat V. Transdermal Delivery of Fentanyl by Electroporation. I: Influence of Electrical Factors. Pharm. Res. 1996; 13: 559–565, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Woodard D.F., Nieves A.L., Williams L.S., Spada C.S., Wawley S.B., Duenes J.L. A New Hairless Strain of Guinea Pig: Characterization of the Cutaneous Morphology and Pharmacology. Models in Dermatology, H.I. Maibach, N.J. Lowe. Karger, Basel 1989; Vol. 4: 71–78
   Google Scholar
• Buehler E.V., Kreuzmann J.J., Sakr A., Gu X.H. Comparable Sensitivity of Hairless and Hartley Strain Guinea Pigs to a Primary Irritant and a Sensitizer. J. Toxicol. Cutan. Ocul. Toxicol. 1990; 9: 163–168
   Web of Science ®Google Scholar
• Chester A.E., Terrell T.G., Nave E., Dorr A.E., DePass L.R. Dermal Sensitization Study in Hairless Guinea Pigs with Dinitrochlorobenzene and Ethyl Aminobenzoate. J. Toxicol. Cutan. Ocul. Toxicol. 1988; 7: 273–281
   Web of Science ®Google Scholar
• Ademola J., Maibach H.I. Safety Assessment of Transdermal and Topical Dermatological Products. Transdermal and Topical Drug Delivery Systems, T.K. Ghosh, W.R. Pfister, S.I. Yum. Interpharm Press, Buffalo Grove 1997; 191–214
   Google Scholar
• Buehler E.V. Prospective Testing for Delayed Contact Hypersensitivity in Guinea Pigs: The Buehler Method. Methods in Immunotoxicol, G.R. Burleson, J.H. Dean, A.E. Munson. Wiley-Liss, New York 1995; Vol. 2: 343–356
   Google Scholar
• Prevo M., Cormier M., Nichols K. Predictive Toxicology Methods for Transdermal Delivery Systems. Dermatotoxicology, F.N. Marzulli, H.I. Maibach. 5th Ed., Taylor & Francis, Washington, DC 1996; 397–410
   Google Scholar
• Guideline for Industry Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies. Federal Register (60 FR 11264), March 1, 1995.
   Google Scholar
• Keister J.C., Kasting G.B. The Use of Transient Diffusion to Investigate Transport Pathways Through Skin. J. Controlled Release 1986; 4: 111–117, [CROSSREF]
   Google Scholar
• Illel B., Schaefer H., Wepierre J. Follicles Play an Important Role in Percutaneous Absorption. J. Pharm. Sci. 1991; 80: 424–427, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Kao J., Hall J., Helman G. In Vitro Percutaneous Absorption in Mouse Skin: Influence of Skin Appendages. Toxicol. Appl. Pharmacol. 1988; 94: 93–103, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rolland A., Wagner N., Chatelus A., Shroot B., Schaefer H. Site-Specific Drug Delivery to Pilosebaceous Structures Using Polymeric Microspheres. Pharm. Res. 1993; 10: 1738–1744, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bidmon H.J., Pitts J.D., Solomon H.F., Bondi J.V., Stumpf W.E. Estradiol Distribution and Penetration in Rat Skin after Topical Application, Studied by High Resolution Autoradiography. Histochemistry 1990; 95: 43–54, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Lauer A.C., Lieb L.M., Ramachandran C., Flynn G.L., Weiner N.D. Transfollicular Drug Delivery. Pharm. Res. 1995; 12: 179–186, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Michaels A.S., Chandrasekaran S.K., Shaw J.E. Drug Permeation Through Human Skin: Theory and In Vitro Experimental Measurement. AICHE J. 1975; 21: 985–996, [CROSSREF]
   Web of Science ®Google Scholar
• Chandrasekaran S.K., Michaels A.S., Campbell P.S., Shaw J.E. Scopolamine Permeation Through Human Skin In Vitro. AICHE J. 1976; 22: 828–832, [CROSSREF]
   Web of Science ®Google Scholar
• Guy R.H., Carlstrom E.M., Bucks D.A.W., Hinz R.S., Maibach H.I. Percutaneous Penetration of Nicotinates: In Vivo and In Vitro Measurements. J. Pharm. Sci. 1986; 75: 968–972, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Friend D.R. In Vitro Skin Permeation Techniques. J. Controlled Release 1992; 18: 235–248, [CROSSREF]
   Web of Science ®Google Scholar
• Spencer T.S. Preclinical Assessment of Transdermal Drug Delivery Systems. Transdermal and Topical Drug Delivery Systems, T.K. Ghosh, W.R. Pfister, S.I. Yum. Interpharm Press, Buffalo Grove 1997; 167–179
   Google Scholar
• Kasting G.B., Filloon T.G., Francis W.R., Meredith M.P. Improving the Sensitivity of In Vitro Skin Penetration Experiments. Pharm. Res. 1994; 11: 1747–1754, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Skelly J.P., Shah V.P., Maibach H.I., Guy R.H., Wester R.C., Flynn G., Yacobi A. FDA and AAPS Report of the Workshop on Principles and Practices of In Vitro Percutaneous Penetration Studies: Relevance to Bioavailability and Bioequivalence. Pharm. Res. 1987; 4: 265–267, [CROSSREF]
   Web of Science ®Google Scholar
• Franz T.J. Percutaneous Absorption. On the Relevance of In Vitro Data. J. Invest. Dermatol. 1975; 64: 190–195, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rougier A., Lotte C., Maibach H.I. In Vivo Percutaneous Penetration of Some Organic Compounds Related to Anatomic Site in Humans: Predictive Assessment by the Stripping Method. J. Pharm. Sci. 1987; 76: 451–454, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Shah A.K., Wei G., Lanman R.C., Bhargava V.O., Weir S.J. Percutaneous Absorption of Ketoprofen from Different Anatomical Sites in Man. Pharm. Res. 1996; 13: 168–172, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kasting G.B., Bowman L.A. Electrical Analysis of Fresh, Excised Human Skin: A Comparison with Frozen Skin. Pharm. Res. 1990; 7: 1141–1146, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Franz T.J., Lehman P.A. The Use of Water Permeability as a Means of Validation for Skin Integrity in In Vitro Percutaneous Absorption Studies. J. Invest. Dermatol. 1990; 95: 525
   Google Scholar
• Kasting G.B., Bowman L.A. DC Electrical Properties of Frozen, Excised Human Skin. Pharm. Res. 1990; 7: 134–143, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kao J., Patterson F.K., Hall J. Skin Penetration and Metabolism of Topically Applied Chemicals in Six Mammalian Species, Including Man: An In Vitro Study with Benzo[a]Pyrene and Testosterone. Toxical. Appl. Pharmacol. 1985; 81: 502–516, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wester R.C., Christoffel J., Hartway T., Poblete N., Maibach H.I., Forsell J. Human Cadaver Skin Viability for In Vitro Percutaneous Absorption: Storage and Detrimental Effects of Heat-Separation and Freezing. Pharm. Res. 1998; 15: 82–84, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Raffali F., Rougier A., Roguet R. Measurement and Modulation of Cytochrome-P450 Dependent Enzyme Activity in Cultured Human Keratinocytes. Skin Pharmacol. 1994; 7: 345–354, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Coulomb B., Lebreton C., Dubertret L. The Skin Equivalent: A Model for Skin and General Pharmacology. Models in Dermatology, H.I. Maibach, N.J. Lowe. Karger, Basel 1989; Vol. 4: 20–29
   Google Scholar
• Loper, A.E.; Michaels, A.S.; Bamopoulos, G.; Ng, L.L.; Bondi, J.V.; Cohen, E.M. Drug Transport Through Membranes from a Reservoir with Time-Dependent Diffusional Resistance. Proceedings of the 11th International Symposium of Controlled Release of Bioactive Materials, 1984.
   Google Scholar
• Hojyo-Tomoka M.T., Kligman A.M. Does Cellophane Tape Stripping Remove the Horny Layer?. Arch. Dermatol. 1972; 106: 767–768, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bronaugh R.L., Stewart R.F. Methods for In Vitro Percutaneous Absorption Studies. V: Permeation Through Damaged Skin. J. Pharm. Sci. 1985; 74: 1062–1066, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Turner N.G., Kalia Y.N., Guy R.H. The Effect of Current on Skin Barrier Function In Vivo: Recovery Kinetics Post-Iontophoresis. Pharm. Res. 1997; 14: 1252–1257, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Flynn G.L., Yalkowsky S.H., Roseman T.J. Mass Transport Phenomena and Models: Theoretical Concepts. J. Pharm. Sci. 1974; 63: 1276–1280, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Palm J., Ferguson F.G. Fuzzy, a Hypotrichotic Mutant in Linkage Group I of the Norway Rat. J. Hered. 1976; 67: 284–288, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Loper A.E., Grabowski L.A., Fong E.K., Wiernik M.D., Bondi J.V. Fuzzy Rat Skin as a Surrogate for Cadaver Skin for In Vitro Diffusion Studies. Pharm. Res. 1986; 3: 72S
   Google Scholar
• Bronaugh R.L., Stewart R.F. Methods for In Vitro Percutaneous Absorption Studies. VI: Preparation of the Barrier Layer. J. Pharm. Sci. 1986; 75: 487–491, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Krueger G.G., Wojciechowski Z.J., Burton S.A., Gilhar A., Huether S.E., Leonard L.G., Rohr U.D., Petelenz T.J., Higuchi W.I., Pershing L.K. The Development of a Rat/Human Skin Flap Served by a Defined and Accessible Vasculature on a Congenitally Athymic (Nude) Rat. Fundam. Appl. Toxicol. 1985; 6: S112–S121, [CROSSREF]
   Google Scholar
• Riviere J.E., Bowman K.F., Monteiro-Riviere N.A., Dix L.P., Carver M.P. The Isolated Perfused Porcine Skin Flap (IPPSF). Fundam. Appl. Toxicol. 1986; 7: 444–453, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Cheriathundam E., Almirez R., Alvares A.P. Comparisons of Hepatic and Renal Cytochrome P-450-Dependent Monooxygenases from Fuzzy and Sprague–Dawley Rats. Drug Metab. Dispos. 1992; 20: 19–22, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Muck W.M., Henion J.D. High-Performance Liquid Chromatography/Tandem Mass Spectrometry: Its Use for the Identification of Stanozolol and Its Major Metabolites in Human and Equine Urine. Biomed. Environ. Mass Spectrom. 1990; 19: 37–51, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Olah T.V., McLoughlin D.A., Gilbert J.D. The Simultaneous Determination of Mixtures of Drug Candidates by Liquid Chromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry as an In Vivo Drug Screening Procedure. Rapid Commun. Mass Spectrom. 1997; 11: 17–23, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Noonan P.K., Wester R.C. Cutaneous Metabolism of Xenobiotics. Percutaneous Absorption Mechanisms—Methodology—Drug Delivery, R.L. Bronaugh, H.I. Maibach. Marcel Dekker, New York 1985; 65–85
   Google Scholar
• Bucks D.A.W. Skin Structure and Metabolism: Relevance to the Design of Cutaneous Therapeutics. Pharm. Res. 1984; 1: 148–153, [CROSSREF]
   PubMedGoogle Scholar
• Martin R.J., Denyer S.P., Hadgraft J. Skin Metabolism of Topically Applied Compounds. Int. J. Pharm. 1987; 39: 23–32, [CROSSREF]
   Web of Science ®Google Scholar
• Loo J.C., Riegelman S. New Method for Calculating the Intrinsic Absorption Rate of Drugs. J. Pharm. Sci. 1968; 57: 918–928, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Yacobi A., Baughman R.A., Cosulich D.B., Nicolau G. Method for Determination of First-Pass Metabolism in Human Skin. J. Pharm. Sci. 1984; 73: 1499–1500, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gillespie W.R., Veng Pedersen P. A Polyexponential Deconvolution Method. Evaluation of the Gastrointestinal Bioavailability and Mean In Vivo Dissolution Time of Some Ibuprofen Dosage Forms. J. Pharmacokinet. Biopharm. 1985; 13: 289–307, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wagner J.G. Pharmacokinetics for the Pharmaceutical Scientist. Technomic Publishing, Lancaster 1993; 159–206
   Google Scholar
• Guideline for Industry Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies. Federal Register 1995, 60(40), 11274–11275.
   Google Scholar
• Brown W.R., Hardy M.H. The Asebia Mouse: An Animal Model of Psoriasiform Disease. Models in Dermatology, H.I. Maibach, N.J. Lowe. S. Karger, New York 1985; Vol. 1: 220–227
   Google Scholar
• Puhvel S.M. Animal Models for Comedolytic Agents. Models in Dermatology, H.I. Maibach, N.J. Lowe. S. Karger, New York 1985; Vol. 2: 64–69
   Google Scholar
• Shah V.P., Flynn G.L., Yacobi A., Maibach H.I., Bon C., Fleischer N.M., Franz T.J., Kaplan S.A., Kawamoto J., Lesko L.J., Marty J.P., Pershing L.K., Schaefer H., Sequeira J., Shrivastava S., Wilkin J., Williams R. AAPS/FDA Workshop Report Bioequivalence of Topical Dermatological Dosage Forms—Methods of Evaluation of Bioequivalence. Pharm. Technol. 1998; 140–148, March
   Google Scholar
• Vickers C.F.H. Stratum Corneum Reservoir for Drugs. Advances in Biology of Skin, Pharmacology and the Skin, W. Montagna, E.J. Van Scott, R.B. Stoughton. Appleton-Century-Crofts, New York 1969; Vol. 12: 177–189
   Google Scholar
• Fong E.K., Frank J.D., Cartwright M.E., Loper A.E. Improved Method for Rhesus Monkey or Rat Skin Preparation and Cryosectioning for Topical or Transdermal Skin Distribution Studies. Exp. Dermatol. 1996; 5: 45–48, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Neelissen J.A.M. Visualization of Percutaneous Steroid Transport. Leiden University, The Netherlands 1962
   Google Scholar
• Anderson C., Andersson T., Boman A. Cutaneous Microdialysis for Human In Vivo Dermal Absorption Studies. Dermal Absorption and Toxicity Assessment, M.S. Roberts, K.A. Walters. Marcel Dekker, New York 1998; 231–244
   Google Scholar
• Auletta C.S. Acute, Subchronic and Chronic Toxicology. CRC Handbook of Toxicology, M.J. Derelanko, M.A. Hollinger. CRC Press, Boca Raton, FL 1995; 51–104
   Google Scholar
• Rush R.E., Bonnette K.L., Douds D.A., Merriman T.N. Dermal Irritation and Sensitization. CRC Handbook of Toxicology, M.J. Derelanko, M.A. Hollinger. CRC Press, Boca Raton, FL 1995; 105–162
   Google Scholar
• Lawrence J.N. Application of In Vitro Human Skin Models to Dermal Irritancy: A Brief Overview and Future Prospects. Toxicol. In Vitro 1997; 11: 305–312, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Draize J.H., Woodard G., Calvery H.O. Methods for the Study of Irritation and Toxicity of Substances Applied Topically to the Skin and Mucous Membranes. J. Pharmacol. Exp. Ther. 1944; 82: 377–390
   Web of Science ®Google Scholar
• Klein-Szanto A.J.P., Conti C.J., Aldaz C.M. Skin and Oral Mucosa. Handbook of Toxicologic Pathology, W.M. Haschek, C.G. Rousseaux. Academic Press, San Diego 1991; 165–193
   Google Scholar
• de Silva O., Basketter D.A., Barratt M.D., Corsini E., Cronin M.T.D., Das P.K., Degwert J., Enk A., Garrigue J.L., Hauser C., Kimber I., Lepoittevin J.-P., Peguet J., Ponec M. Alternative Methods for Skin Sensitisation Testing: the Report and Recommendations of ECVAM Workshop 19. ALTA 1996; 24: 683–705
   Google Scholar
• Bour H., Krasteva M., Nicolas J.-F. Allergic Contact Dermatitis. Skin Immune System (SIS): Cutaneous Immunology and Clinical Immunodermatology, J.S. Bos. 2nd Ed., CRC Press, Boca Raton, FL 1997; 509–522
   Google Scholar
• Gad S.C. Safety Evaluation of Medical Devices. Marcel Dekker, New York 1997; 131–188
   Google Scholar
• Kimber I., Dearman R.J. Contact Hypersensitivity: Immunological Mechanisms. Toxicology of Contact Hypersensitivity, I. Kimber, T. Maurer. Taylor & Francis, London 1996; 4–25
   Google Scholar
• Patrick E., Maibach H.I. Principles and Methods of Toxicology, A.W. Hayes. 3rd Ed., Raven Press, New York 1994; 767–803
   Google Scholar
• Scheper R.J., von Blomberg B.M.E. Mechanisms of Allergic Contact Dermatitis to Chemicals. Allergic Hypersensitivities Induced by Chemicals: Recommendations for Prevention, J.G. Vos, M. Younes, E. Smith. CRC Press, Boca Raton, FL 1996; 185–201
   Google Scholar
• Klecak G. Test Methods for Allergic Contact Dermatitis in Animals. Dermatotoxicology Methods: the Laboratory Worker's Vade Mecum, F.N. Marzulli, H.I. Maibach. Taylor & Francis, Washington DC 1998; 121–143
   Google Scholar
• Maurer T. Guinea Pig Predictive Tests. Toxicology of Contact Hypersensitivity, I. Kimber, T. Maurer. Taylor & Francis, London 1996; 107–126
   Google Scholar
• Prevo M., Cormier M., Matriano J. Developing a Toxicology Evaluation Plan for Transdermal Delivery Systems. Dermatotoxicology Methods: the Laboratory Worker's Vade Mecum, F.N. Marzulli, H.I. Maibach. Taylor & Francis, Washington DC 1998; 75–87
   Google Scholar
• Maguire H.C. Estimation of the Allergenicity of Prospective Human Contact Sensitizers in the Guinea Pig. Animal Models in Dermatology, H.I. Maibach. Churchill Livingstone, New York 1975; 67–75
   Google Scholar
• Griffith J.F. Predictive and Diagnostic Testing for Contact Sensitization. Toxicol. Appl. Pharmacol. 1969; 3: 90–102
   Google Scholar
• Buehler E.V. Delayed Contact Hypersensitivity in the Guinea Pig. Arch. Dermatol. 1965; 91: 171–175, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Basketter D.A., Cookman G., Gerberick G.F., Hamaide N., Potokar M. Skin Sensitization Thresholds: Determination in Predictive Models. Food. Chem. Toxicol. 1997; 35: 417–425, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Haeberlin B., Friend D.R. Anatomy and Physiology of the Gastrointestinal Tract: Implications for Colonic Drug Delivery. Oral Colon-Specific Drug Delivery, D.R. Friend. CRC Press, Boca Raton, FL 1992; 1–43
   Google Scholar
• Braun-Falco O., Korting H.C. Normal pH Value of Human Skin. Hautarzt 1986; 37: 126–129, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Matsushima D., Prevo M.E., Gorsline J. Absorption and Adverse Effects Following Topical and Oral Administration of Three Transdermal Nicotine Products to Dogs. J. Pharm. Sci. 1995; 84: 365–369, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• United States Pharmacopoeia 23/National Formulary 18. Rockville, MD: United States Pharmacopoeia Convention, 1995, pp 1699–1703.
   Google Scholar
• Freshney R.I. Measurement of Viaibility and Cytotoxicity. Culture of Animal Cells: A Manual of Basic Technique, R.I. Freshney. 3rd Ed., Wiley-Liss, New York 1994; 287–307
   Google Scholar
• Mosmann T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods 1983; 65: 55–63, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gad S.C. Safety Evaluation of Medical Devices. Marcel Dekker, New York 1997; 75–84
   Google Scholar
• United States Pharmacopeia 23/National Formulary 18. Rockville, MD: United States Pharmacopeial Convention, 1995, pp 1697–1699.
   Google Scholar
• Wier P.J., Wise L.D. Middle Atlantic Reproduction and Teratology Association: Bibliography of Reproductive and Developmental Toxicology Test Guidelines and Related Publications. Developmental Toxicology, R.D. Hood. CRC Press, Boca Raton 1997; 735–749
   Google Scholar
• Ecobichon D.J. Reproductive Toxicology. The Basis of Toxicity Testing, D.J. Ecobichon. 2nd Ed., CRC Press, Boca Raton, FL 1997; 117–156
   Google Scholar
• Ecobichon D.J. Reproductive Toxicology. CRC Handbook of Toxicology, M.J. Derelanko, M.A. Hollinger. CRC Press, Boca Raton, FL 1995; 379–402
   Google Scholar
• MacKenzie K.M., Hoar R.M. Developmental Toxicology. CRC Handbook of Toxicology, M.J. Derelanko, M.A. Hollinger. CRC Press, Boca Raton, FL 1995; 403–450
   Google Scholar
• Manson J.M., Kang Y.J. Test Methods for Assessing Female Reproductive and Developmental Toxicology. Principles and Methods of Toxicology, A.W. Hayes. 3rd Ed., Raven Press, New York 1994; 989–1037
   Google Scholar
• Rogers J.M., Kavlock R.J. Developmental Toxicology. Casarett & Doull's Toxicology: The Basic Science of Poisons, C.D. Klaassen. 5th Ed., McGraw-Hill, New York 1996; 301–331
   Google Scholar
• Thomas J.A. Toxic Responses of the Reproductive System. Casarett & Doull's Toxicology: The Basic Science of Poisons, C.D. Klaassen. 5th Ed., McGraw-Hill, New York 1996; 547–581
   Google Scholar
• Kimmel C.A., Francis E.Z. Proceedings of the Workshop on the Acceptability and Interpretation of Dermal Developmental Toxicity Studies. Fundam. Appl. Toxicol. 1990; 14: 386–398, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Rogers J.M., Kavlock R.J. Developmental Toxicology. Casarett & Doull's Toxicology: The Basic Science of Poisons, C.D. Klaassen. McGraw-Hill, New York 1996; 301–331
   Google Scholar
• Becci P.J., Knickerbocker M.J., Reagan E.L., Parent R.A., Burnette L.W. Teratogenicity Study of N-Methylpyrrolidone after Dermal Application to Sprague–Dawley Rats. Fundam. Appl. Toxicol. 1982; 2: 73–76, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Feuston M.H., Mackerer C.R. Developmental Toxicity Study in Rats Exposed Dermally to Clarified Slurry Oil for a Limited Period of Gestation. J. Toxicol. Environ. Health 1996; 49: 207–220, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Feuston M.H., Mackerer C.R., Schreiner C.A., Hamilton C.E. Systemic Toxicity of Dermally Applied Crude Oils in Rats. J. Toxicol. Environ. Health 1997; 51: 387–399, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Feuston M.H., Kerstetter S.L., Singer E.J., Mehlman M.A. Developmental Toxicity of Clarified Slurry Oil Applied Dermally to Rats. Toxicol. Ind. Health 1989; 5: 587–599, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Feuston M.H., Kerstetter S.L., Wilson P.D. Teratogenicity of 2-Methoxyethanol Applied as a Single Dermal Dose to Rats. Fundam. Appl. Toxicol. 1990; 15: 448–456, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Hoberman A.M., Christian M.S., Lovre S., Roth R., Koschier F. Developmental Toxicity Study of Clarified Slurry Oil (CSO) in the Rat. Fundam. Appl. Toxicol. 1995; 1: 34–40, [CROSSREF]
   Google Scholar
• Seegmiller R.E., Carter M.W., Ford W.H., White R.D. Induction of Maternal Toxicity in the Rat by Dermal Application of Retinoic Acid and Its Effect on Fetal Outcome. Reprod. Toxicol. 1990; 4: 277–281, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Tyl R.W., Fisher L.C., Kubena M.F., Vrbanic M.A., Gingell R., Guest D., Hodgson J.R., Murphy S.R., Tyler T.R., Astill B.D. The Developmental Toxicity of 2-Ethylhexanol Applied Dermally to Pregnant Fischer 344 Rats. Fundam. Appl. Toxicol. 1992; 19: 176–185, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Forbes P.D., Sambuco C.P., Dearlove G.E., Parker R.M., Kiorpes A.L., Wedig J.H. Sample Protocols for Carcinogenesis and Photocarcinogenesis. Dermatotoxicology Methods: The Laboratory Worker's Vade Mecum, F.N. Marzulli, H.I. Maibach. Taylor & Francis, Washington, DC 1998; 281–302
   Google Scholar
• Marzulli F.N., Maibach H.I. Photoirritation (Phototoxicity, Phototoxic Dermatitis). Dermatotoxicology, F.N. Marzulli, H.I. Maibach. 5th Ed., Taylor & Francis, Washington, DC 1996; 231–237
   Google Scholar
• Lambert L.A., Wamer W.G., Kornhauser A. Animal Models for Phototoxicity Testing. Dermatotoxicology, F.N. Marzulli, H.I. Maibach. 5th Ed., Taylor & Francis, Washington, DC 1996; 515–529
   Google Scholar
• Forbes P.D. Carcinogenesis and Photocarcinogenesis Test Methods. Dermatotoxicology, F.N. Marzulli, H.I. Maibach. 5th Ed., Taylor & Francis, Washington, DC 1996; 535–544
   Google Scholar